Atrovent HFA
FDA Approves Breo Ellipta to Treat COPD »
"The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary di"...
Atrovent HFA
OVERDOSE
Acute overdose by inhalation is unlikely since ipratropium bromide is not well absorbed systemically after inhalation or oral administration.
CONTRAINDICATIONS
ATROVENT HFA is contraindicated in the following conditions [see WARNINGS AND PRECAUTIONS].
- Hypersensitivity to ipratropium bromide or other ATROVENT HFA components
- Hypersensitivity to atropine or any of its derivatives
Last reviewed on RxList: 10/8/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Atrovent HFA Information
Atrovent HFA - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.






